Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system☆☆☆
To access this article, please choose from the options below
☆ This work was supported under contract with the Division of Microbiology and Infectious Diseases of the National Institute of Allergy and Infectious Diseases (NIAID) (N01-AI-30025, N01-AI-65306, N01-AI-15113, N01-AI-62554), and by grants from the General Clinical Research Center Program (M01-RR00032) and the State of Alabama.
☆☆ Trial Registration. Clinicaltrials.gov identifier: NCT00001100.
PII: S1386-6532(09)00389-8
doi:10.1016/j.jcv.2009.08.012
© 2009 Elsevier B.V. All rights reserved.
